Literature DB >> 7326870

Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration.

J S Greenspan, N Gadol, J A Olson, N Talal.   

Abstract

Antibody-dependent cellular cytotoxicity (ADCC) was investigated as s possible mechanism of pathogenesis in recurrent aphthous ulceration (RAU). ADCC induced by mononuclear cells from patients at various stages of RAU was compared with ADCC induced by mononuclear cells from paired controls. Chicken red blood cells (ChRBC) coated with rabbit anti-ChRBC antibody were used as targets. A significant increase in ADCC (P less than 0.01, paired sample t-test) in patients' samples as compared with controls was found only at the early stage of the disease. No increased cytotoxicity over control values was observed at any other single stage of the disease. The transient increased cytotoxicity observed in the early stage of RAU may reflect a number of possible mechanisms, including an increased number of ADCC effector cells only at the early stage, an increase in Fc receptor avidity, or an increase in efficiency of the existing effector cell population.

Entities:  

Mesh:

Year:  1981        PMID: 7326870      PMCID: PMC1537328     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Antibody-dependent killing of Cryptococcus neopormans by human peripheral blood mononuclear cells.

Authors:  R D Diamond
Journal:  Nature       Date:  1974-01-18       Impact factor: 49.962

2.  Adenovirus isolation from recurrent oral ulcers.

Authors:  K Sallay; G Kulcsar; I Nasz; P Dan; P Geck
Journal:  J Periodontol       Date:  1973-11       Impact factor: 6.993

3.  Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome.

Authors:  R S Rogers; W M Sams; R G Shorter
Journal:  Arch Dermatol       Date:  1974-03

4.  Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.

Authors:  T R Hakala; P H Lange; A E Castro; A Y Elliott; E E Fraley
Journal:  N Engl J Med       Date:  1974-09-26       Impact factor: 91.245

5.  In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.

Authors:  H Mellstedt; G Holm
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

6.  Recurrent aphthous ulceration. Effect of sera and peripheral blood lymphocytes upon oral epithelial tissue culture cells.

Authors:  A E Dolby
Journal:  Immunology       Date:  1969-11       Impact factor: 7.397

7.  Impaired lymphocyte stimulation by some streptococcal antigens in patients with recurrent aphthous stomatitis and rheumatic heart disease.

Authors:  T C Francis; J J Oppenheim
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

8.  Characterization of mucosal antibodies in recurrent aphthous ulceration and Behcet's syndrome.

Authors:  T Lehner
Journal:  Arch Oral Biol       Date:  1969-07       Impact factor: 2.633

9.  Portal hypertension from idiopathic superior vena caval obstruction.

Authors:  E W Fonkalsrud; L M Linde; W P Longmire
Journal:  JAMA       Date:  1966-04-11       Impact factor: 56.272

10.  Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.

Authors:  C O'Toole; V Stejskal; P Perlmann; M Karlsson
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  4 in total

1.  Aphthous ulceration.

Authors: 
Journal:  J R Soc Med       Date:  1984-01       Impact factor: 5.344

2.  Carboxylate-dependent gelation of a monoclonal antibody.

Authors:  Osigwe Esue; Sonoko Kanai; Jun Liu; Thomas W Patapoff; Steven J Shire
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

3.  Characterisation of the effector cells responsible for the in vitro cytotoxicity of blood leucocytes from aphthous ulcer patients for oral epithelial cells.

Authors:  D W Thomas; J Bagg; D M Walker
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

4.  Amlexanox for the treatment of recurrent aphthous ulcers.

Authors:  Juliette Bell
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.